Recent Advances in Pathology: the 2021 Annual Review Issue of The Journal of Pathology
Open Access
- 7 June 2021
- journal article
- editorial
- Published by Wiley in The Journal of Pathology
- Vol. 254 (4) , 303-306
Abstract
The 2021 Annual Review Issue of The Journal of Pathology contains 14 invited reviews on current research areas of particular importance in pathology. The subjects included here reflect the broad range of interests covered by the journal, including both basic and applied research fields but always with the aim of improving our understanding of human disease. This year, our reviews encompass the huge impact of the COVID‐19 pandemic, the development and application of biomarkers for immune checkpoint inhibitors, recent advances in multiplexing antigen/nucleic acid detection in situ, the use of genomics to aid drug discovery, organoid methodologies in research, the microbiome in cancer, the role of macrophage‐stroma interactions in fibrosis, and TGF‐β as a driver of fibrosis in multiple pathologies. Other reviews revisit the p53 field and its lack of clinical impact to date, dissect the genetics of mitochondrial diseases, summarise the cells of origin and genetics of sarcomagenesis, provide new data on the role of TRIM28 in tumour predisposition, review our current understanding of cancer stem cell niches, and the function and regulation of p63. The reviews are authored by experts in their field from academia and industry, and provide comprehensive updates of the chosen areas, in which there has been considerable recent progress. © 2021 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
This publication has 15 references indexed in Scilit:
- An emerging role for cellular crosstalk in the cancer stem cell nicheThe Journal of Pathology, 2021
- Clinical and research applications of multiplexed immunohistochemistry and in situ hybridizationThe Journal of Pathology, 2021
- The microbiome(s) and cancer: know thy neighbor(s)The Journal of Pathology, 2021
- The foggy world(s) of p63 isoform regulation in normal cells and cancerThe Journal of Pathology, 2021
- COVID‐19: immunopathology, pathophysiological mechanisms, and treatment optionsThe Journal of Pathology, 2021
- The genetics of mitochondrial disease: dissecting mitochondrial pathology using multi‐omic pipelinesThe Journal of Pathology, 2021
- TRIM28 variants and Wilms' tumour predispositionThe Journal of Pathology, 2021
- Macrophage–stroma interactions in fibrosis: biochemical, biophysical, and cellular perspectivesThe Journal of Pathology, 2021
- Genetic drivers and cells of origin in sarcomagenesisThe Journal of Pathology, 2021
- Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19)The Journal of Pathology, 2020